S.A Therabel-Pharma N.V. SA
28.3 FTES.A Therabel-Pharma N.V. reported revenue of €15.7m for the 2025 financial year (annual accounts filed with the NBB on 10 Jun 2026), with 28.3 full-time equivalents.
By total assets for 2025, S.A Therabel-Pharma N.V. ranks among the 200 largest of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of S.A Therabel-Pharma N.V. shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -7 % Equity -25 % Total assets -3 % Headcount (avg FTE) -29 %
Accounts of the company itself (not consolidated).
The full file covers 19 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
S.A Therabel-Pharma N.V.'s annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €15.7m | ||||
| Net result | −98,457 € | ||||
| Equity | €4.14m | ||||
| Cash | 402,211 € | ||||
| EBITDA | −€4.51m | ||||
| Total assets | €12.8m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jun 2026
- Year ended 31 Dec 2024filed on 06 Jun 2025
- Year ended 31 Dec 2023filed on 22 Jul 2024
- Year ended 31 Dec 2022filed on 15 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
S.A Therabel-Pharma N.V.'s financial analysis
- Solvency32.2%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of S.A Therabel-Pharma N.V.
S.A Therabel-Pharma N.V.'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0420.515.586
- VAT number
- BE0420515586
- Peppol
- Registered · 0208:0420515586 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 16 Apr 1980
- Registered office
- 1190 Forest
- Size
- Small · 28.3 FTE
- Latest accounts
- 2025 · filed on 10 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
S.A Therabel-Pharma N.V. (SA) has been based in Forest since 1980, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €15.7m, a net loss of 98,457 € and equity of €4.14m. With 28.3 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 32.2%, below the median of its sector (32.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to S.A Therabel-Pharma N.V.
Companies in the same business, of comparable size and area, outside its group.
- URGO Activities of agents involved in non-specialised wholesale Uccle · balance sheet €17.1m
- Coloplast Belgium Wholesale of pharmaceutical and medical goods Beersel · balance sheet €16.8m
- BIOCODEX Benelux Wholesale of pharmaceutical and medical goods Forest · balance sheet €8.15m
- Servier Benelux Wholesale of pharmaceutical and medical goods Anderlecht · balance sheet €61.5m
- SPGL Ltd Wholesale of pharmaceutical and medical goods · balance sheet €1.01m
- Bofar Wholesale of pharmaceutical and medical goods Wingene · balance sheet €12.2m
- Sanmedex Wholesale of pharmaceutical and medical goods Uccle · balance sheet 50,961 €
- Ceres Pharmaceuticals Wholesale of pharmaceutical and medical goods Ghent · balance sheet €9.46m
Frequently asked questions about S.A Therabel-Pharma N.V.
What is the revenue of S.A Therabel-Pharma N.V.?
According to the 2025 annual accounts filed with the NBB, the revenue of S.A Therabel-Pharma N.V. amounts to 15,749,710 €.
What is the VAT number of S.A Therabel-Pharma N.V.?
In Belgium, the VAT number is the company number prefixed with BE: BE0420515586 for S.A Therabel-Pharma N.V., if the company is VAT-registered. Its company number (CBE) is 0420.515.586.
Where is the registered office of S.A Therabel-Pharma N.V.?
According to the CBE register, the registered office of S.A Therabel-Pharma N.V. is in 1190 Forest.
What is the equity of S.A Therabel-Pharma N.V.?
At the close of the 2025 financial year, the equity of S.A Therabel-Pharma N.V. amounts to 4,138,297 €, a solvency of 32.2% of total assets.
How many people work at S.A Therabel-Pharma N.V.?
28.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages S.A Therabel-Pharma N.V.?
The register lists 5 active mandates at S.A Therabel-Pharma N.V.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is S.A Therabel-Pharma N.V. within its sector?
By total assets for 2025, S.A Therabel-Pharma N.V. ranks among the 200 largest of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of S.A Therabel-Pharma N.V.
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →